Nasdaq · CIK 0001873875
IXHL Incannex Healthcare Inc.
Insider trading from SEC Form 4. Last filing Nov 14, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at Incannex Healthcare Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 7 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | George Anastassov director | AGrant or award Common Stock, $0.0001 par value per share | +1,686,956 | $0.00 | $0 | 2,456,677 | Nov 14, 2025 |
| Nov 14, 2025 | Robert Clark director | AGrant or award Common Stock, $0.0001 par value per share | +1,686,956 | $0.00 | $0 | 1,786,956 | Nov 14, 2025 |
| Nov 14, 2025 | Joel Latham CEO and President | AGrant or award Common Stock, $0.0001 par value per share | +22,608,692 | $0.00 | $0 | 24,186,177 | Nov 14, 2025 |
| Nov 14, 2025 | Joseph Swan CFO, Treasurer and Secretary | AGrant or award Common Stock, $0.0001 par value per share | +869,565 | $0.00 | $0 | 921,358 | Nov 14, 2025 |
| Nov 14, 2025 | Peter Widdows director | AGrant or award Common Stock, $0.0001 par value per share | +1,686,956 | $0.00 | $0 | 1,957,803 | Nov 14, 2025 |
| Nov 14, 2025 | Troy Valentine director | AGrant or award Common Stock, $0.0001 par value per share | +11,302,608 | $0.00 | $0 | 12,001,858 | Nov 14, 2025 |
| Oct 23, 2024 | Luigi M. Barbato Chief Medical Officer | AGrant or award Common Stock | +100,476 | $0.00 | $0 | 100,476 | Oct 24, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- George Anastassovdirector
- Luigi M. BarbatoChief Medical Officer
- Robert Clarkdirector
- Joel LathamCEO and President
- Joseph SwanCFO, Treasurer and Secretary
- Troy Valentinedirector
- Peter Widdowsdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.